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Abstract
Background: Systemic Lupus Erythematosus (SLE) is a serious multisystem autoimmune disease, which is more
aggressive in children and people of African descent. In South Africa, pediatric SLE (pSLE) patients are at high risk
for severe disease. Similar to pSLE worldwide, South African children and adolescents with SLE require subspecialized
medical care. The aim of this study is to describe the care-seeking experiences of families and examine factors that
contribute to delays in the diagnosis of pSLE. Specifically, we sought to identify factors to inform interventions that
support the timely referral and diagnosis of pediatric SLE patients in South Africa.
Methods: In-depth, semi-structured interviews were conducted with 22 caregivers of pSLE patients recruited from two
government hospitals in Cape Town, South Africa in 2014. Interviews were audio-recorded, transcribed, and analyzed
for themes related to barriers to diagnosis.
Results: Six themes were identified and classified as either caregiver or health system barriers to diagnosis. Caregiver
barriers included lack of knowledge regarding SLE, financial difficulties, and the social stigma of SLE. Health system
barriers were lack of trained staff, a complex medical system, and misdiagnosis.
Conclusion: Caregivers reported missed opportunities for diagnosing pSLE in their children. Raising public awareness
may improve caregiver awareness and reduce stigma of pSLE. Improving family education at diagnosis holds potential to
increase patient-physician trust and mitigate fear. Education modules for primary care providers at initial point of contact
with the health care system may improve recognition of early pSLE and facilitate expedited referral to a specialist.
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Background
Systemic Lupus Erythematosus (SLE) is an autoimmune
disease characterized by multisystem episodic inflamma-
tion leading to severe morbidity and mortality. Prior to
the discovery of corticosteroids, SLE was universally fatal;
life expectancy today is still 10–30 years less than for the
general population [1]. In high-income nations, patients of
African descent have increased rates of lupus nephritis
and end stage renal disease (ESRD), with mortality rates
two to three times greater in African Americans than
Caucasians [2]. Both genetic risk and social determinants
of health influence these outcomes [3, 4]. Individuals diag-
nosed with SLE during childhood accumulate more irre-
versible damage than adult counterparts [5, 6]. Therefore,
children in Africa may be at risk for severe disease, but
little is known about this population [7–9]. The few
studies of SLE in low-income nations have consistently
documented worse disease outcomes compared with
high-income nations [9–11]. Adult SLE studies in South
Africa demonstrate a 5-year survival rate of 67-85%, com-
pared with 95% in the United States [12, 13]. A recent
study of pediatric SLE (pSLE) patients in South Africa de-
scribed high rates of lupus nephritis and increased risk for
progression to ESRD, dialysis and transplant [9], but did
not explore the role of diagnostic delay on outcome.
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South Africa is a low- to middle-income nation and
health-care leader in Africa, yet health care disparities
exist due to racial, political and economic inequities that
have persisted after apartheid [14]. The burden of infec-
tious diseases, trauma, and the HIV epidemic compro-
mises access to health care for patients with chronic
illness [15]. South Africa is highly underserved in pediatric
rheumatology with only five registered pediatric rheuma-
tologists in a country of over 18 million children [16].
Based on estimates from the USA, South Africa would re-
quire 40 additional pediatric rheumatologists to provide
adequate care for its patient population [17].
Timely diagnosis of pSLE significantly improves long-
term outcomes in children. Early diagnosis and treat-
ment reduces organ damage, prevents renal failure, and
improves survival [18, 19]. Previous studies in South
Africa have demonstrated barriers to health care access,
from poor road infrastructure to an inadequate medical
referral system [20, 21]. U.S. studies of adult SLE pa-
tients highlight socioeconomic status, education, and
geographic location as determinants of access to care,
showing such disparities influence long term outcomes
[22, 23].
An in-depth understanding of the path to pSLE diag-
nosis in South Africa is necessary to identify barriers to
timely diagnosis and referral for specialized care, but has
not been addressed in the available literature. Our study
used qualitative interviews to contextually explore the
diagnosis experience for families and identify gaps in
health care access for children with pSLE in South Africa.
Methods
Setting
Participants were recruited through pediatric and adult
rheumatology clinics in two government-funded tertiary
hospitals and one private practice clinic in Cape Town,
South Africa. A single pediatric rheumatology provider
(CS) provides care at both hospitals, and a general
rheumatologist provides care at the private clinic.
Subject recruitment
Caregivers of patients diagnosed with pSLE (fulfilling >4
of 11 ACR SLE classification criteria [24] prior to age
19 years) were eligible to participate. A list of eligible care-
givers was generated from an established registry of pa-
tients with pSLE at two tertiary care, government-funded
university hospitals (Red Cross War Memorial Children’s
Hospital [n = 18]; Groote Schuur Hospital [n = 10] and
one private medical center (Winelands Rheumatology
Centre [n = 2]) in Cape Town, SA.
Of 72 total SLE patient caregivers, 30 were successfully
contacted. Study personnel approached caregivers in-
person, by phone, or by email. Of the 30 caregivers which
were contacted successfully, 26 accepted, 4 declined, 4
were unable to schedule the interview due to illness or a
move, and 22 were interviewed.
Ethical review
The study was approved by the Duke Institutional Review
Board (#Pro00045133) and University of Cape Town
Human Research Ethics Committee (#424/2013). Written
informed consent was obtained in the participant’s pre-
ferred language prior to the interview.
Procedures
Individual in-depth interviews were performed using a
semi-structured interview guide with open-ended ques-
tions exploring care-seeking behavior during the pa-
tient’s initial illness, experiences that led to a pSLE
diagnosis, and specific barriers to diagnosis (Additional
file 1). The interview guide was developed based on a
literature review on health care access in South Africa,
SLE care access worldwide, and discussion among au-
thors [25–27]. A semi-structured interview allowed indi-
vidual flexibility and targeted probing of the participant’s
experience and perspective. Participants were offered the
option to be interviewed at clinic (n = 19) or their home
(n = 3), to reduce the burden of missed work and travel.
Interviews were conducted by a female researcher (LBL)
and lasted 30 to 90 min. For non-English speaking par-
ticipants, interviews were conducted in their primary
language (Afrikaans or isiXhosa, the only non-English
languages spoken by caregivers in this study [Table 1]).
Bilingual or multilingual participants were encouraged
to use the language they spoke most comfortably. In
cases where the language of the interview was not
English (n = 6), a translator who was linguistically and
culturally competent provided simultaneous translation.
Self-described participant race was reported using ra-
cial groups employed in South African population sur-
veys: Coloured, Black, White, and Indian/Asian [16]. In
South Africa, the term “Coloured” refers to a historically
racially heterogeneous ethnic group possessing ancestry
from various Khoisan and Bantu tribes of Southern
Africa, Malaysia, Europe, and Asia; “Black” refers to
those with Southern African Bantu tribal ancestry;
“White” refers to those of European descent; and
“Indian/Asian” refers to those of Indian or Asian ancestry.
Analysis
Interviews were audio recorded and transcribed verba-
tim. The interviews were analyzed using a conventional
content analytic approach to identify and organize re-
current themes related to the study aim of identifying
barriers to pSLE diagnosis [28]. Analysis was conducted
in five steps. First, interviews were reviewed using
inductive analysis to identify emerging themes [29].
Second, major themes identified were reviewed by two
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authors (LBL, MHW) in order to reach consensus [30].
Third, analytic memos were written to summarize con-
tent and organize participant responses [31]. Relevant
quotes were incorporated into the memos to represent
family experiences obtaining a pSLE diagnosis. Fourth,
memos were manually coded for primary thematic cat-
egories related to diagnostic barriers at the level of the
health system or patient. For each of the themes, repre-
sentative quotations were identified as examples, and
corresponding memos and transcripts were revisited to
contextualize participants’ words within their overall
narratives.
Results
The sample consisted of 22 participants, all primary care-
givers of pSLE patients at study enrollment and included
18 mothers, 2 fathers, 1 grandmother, and 1 foster mother.
The caregiver race matched the child in all cases: 16
Coloured, 3 Black, 2 White, and 1 Indian (Table 1). The
monthly household income spanned a wide range (R950
to R10,000 [$70 to $730 USD], median income R1562
[112 USD]). Thirty-six percent of South Africans live
below the established poverty line (R620/$43 USD per
month) [32, 33]. None of the caregivers in this study re-
ported household incomes below that level. However, the
majority of caregivers (59%) were government social wel-
fare grant recipients and would likely be below the poverty
line without social grants. Eighteen percent of caregivers
and patients lived in a home without running water or
electricity. Of the two White caregivers, neither reported
receiving a social grant. All caregivers without running
water and electricity were Black or Coloured.
For the majority of participants, there was a signifi-
cant delay between onset of symptoms and a diagnosis
of pSLE. The mean time to diagnosis was 23.5 weeks
(median 7.5 weeks, range 0.5 to 208 weeks). At the time
of diagnosis, pSLE patients had seen multiple providers,
with increasing symptom severity. The majority of
pSLE patients in this study (63%) had severe symptoms
such as acute renal failure, stroke, or pericarditis re-
quiring intervention at the time of diagnosis. Barriers
to timely diagnosis occurred at the level of the care-
giver and the health system. Below, we present themes
within each level.
Barriers at the caregiver level
We identified caregiver barriers, including lack of know-
ledge regarding SLE, financial obstacles to medical care,
and the social stigma of a SLE diagnosis. Representative
quotes are presented in Table 2.
Caregiver knowledge gap in SLE
Most caregivers had no prior knowledge of SLE, and
thus were unable to recognize symptoms. Caregivers
recognized that their child was ill, but often mistakenly
attributed the symptoms to other causes. As symptoms
evolved or progressed, caregivers were motivated to seek
evaluation or re-evaluation. One caregiver described a
typical escalation in symptoms over time: “She went to
school and she couldn’t walk… [then] she was bed rid-
den and she couldn’t walk at all…I tried to bathe her
and she fainted, and then I knew there was big trouble.”
Table 1 Demographic information of pediatric SLE sample (n= 22)
Characteristics Number Percent














Age of caregiver, years Mean: 44.2
Range: 32–74
Caregiver highest education level
Less than Grade 12 8 36
Grade 12 8 36
University or higher 3 14
Not reported 3 14




Average household income per month Mean R4,693 ($363 USD)
Median R1562 (112 USD)
Entire Range R950–R10,000
($73–800 USD)




Time to diagnosis Mean: 23.6 weeks
Median 7.5 weeks
Range 0.5–208 weeks
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Financial barriers to care
A major barrier was the financial burden of accessing
health care. Caregivers spoke about the lasting financial
impact of hospitalization early in the disease course.
One caregiver highlighted the repercussions of paying
hospital bills on household finances: “Where am I going
to get the money to pay this [bill]? You understand,
what am I going to eat with?” Many missed one or more
days of work, for which they were not paid. In addition,
caregivers had to pay for transport to and from the
medical facility, as the majority of participants lacked ac-
cess to private transportation (Table 1). All of the White
and Indian caregivers in this study had access to private
transport, while only twenty-two percent of Black or
Coloured caregivers did.
Social stigma of SLE
Many families reported that they feared social stigma
due to their children’s symptoms and subsequent
diagnosis of pSLE. Caregivers felt the need to hide the
diagnosis from the community for fear of being stigma-
tized. Caregivers reported that others would think their
child was contagious: “I think they steer clear because
they think they can get the illness. Then I tell them that
it is not [contagious] and they don’t understand.” Care-
givers explained that there was no familiarity with SLE
within the community; therefore, there was a lack of un-
derstanding that pSLE was a chronic, non-communicable
disease.
Barriers to care at the health system level
In addition to patient and caregiver barriers, there were
also health system obstacles to obtaining a diagnosis, in-
cluding the lack of trained personnel at initial care con-
tact, a complex medical system, and misdiagnosis.
Representative quotes are presented in Table 3.
Lack of trained staff
The majority of caregivers went to a local primary care
clinic as their first care contact, where they were seen by
staff nurses or general practitioners. Poor communica-
tion of disease assessment from health care providers to
caregivers was reported frequently. Many participants
reported that they were discharged without further test-
ing or treatment. Others were told to return on a day
when a doctor would be present: “There was some blood
in her pee. I took her to the doctor; it was on a Saturday…
the doctor…gave me some medicine to give her and said if
nothing changed I should come back on Wednesday. We
went back…they kept her for a week but they couldn’t find
out what was wrong …so they made an appointment at
[the Children’s hospital].”
Complex medical system
In South Africa, formal referral is required to access
subspecialty care, including pediatrics (Fig. 1). Most
caregivers first went to a local clinic or day hospital for
care, returning several times to obtain a referral to a
pediatrician: “[We took him for care] …quite a few
times. I explained to [the doctor in the emergency room]
the condition and I showed her everything and she told
me I must come on a Tuesday. The pediatricians will be
there.” Often, they reported that they were referred with-
out explanation of symptoms or possible diagnosis.
In two rare cases, caregivers reported that pSLE was
recognized immediately. One patient was already in
rheumatology care for autoimmune disease and was
Table 2 Caregiver level barriers: themes and illustrative quotations
Theme: Caregiver Knowledge Gap as a Patient Level Barrier
Subject 5 “He had chest pain and headache. We thought
he fell on the stove, nobody saw him fall on
the stove. They assumed it was because he was
in pain and couldn’t move. It was 3 to 4 days he
had this pain and couldn’t get out of bed.”
Subject 18 “She had swollen feet. She had been crossing
through dirty water. I thought her feet became
swollen from playing in that water.”
Subject 19 “At first I thought she was just plain lazy, because
whenever I told her to do the dishes she would
sit…she was always sleepy…she was tired, and
she was itching, her hands were like blotches on
the skin.”
Theme: Financial Barriers for Caregivers
Subject 2 “I did get a [hospital] bill. I told them I don’t pay
this. They said just bring proof…It’s a terrible story.
You have to go for affidavits to say you’re not
working and stuff like that and commissions of
oath you have to get signed and then you have
to take the papers in and it takes a month or two.”
Subject 10 “[Time spent at the hospital] is un-paid time-
that type of thing where you have to take off.”
Subject 12 “When L- (patient) was diagnosed, I was off work
for a month and when I came back they arranged
a tea to raise funds for us.”
Subject 14 “The blood work, doctor and medication…it was
more than 2,000 Rand ($120 USD)…I’m still
paying it off.”
Subject 15 “There has been difficulty because we were not
prepared for it all. Many times we had to take
our bread money to go to the doctor.”
Theme: Social Stigma of sick child
Subject 2 “There’s not a lot of [SLE] awareness…There’s
more awareness of crime and anything else.
Subject 3 “I tell them that… it’s only in his joints and that
it affects his joints and it’s not contagious for
somebody else to get.”
Subject 7 “It’s not that she must stay away from the others…
No, no, no. No she’s not sick. She’s normal.”
Subject 10 “People don’t understand. They have all sorts of
ideas of what lupus is.”
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diagnosed and managed efficiently. Another patient
(the child of two physicians) went directly to a private
physician and was diagnosed within days. These outlying
cases provide a stark contrast to the difficulty most
participants had navigating the complex medical system.
Misdiagnosis
The majority of caregivers (16/22) reported misdiagnosis
at least once and frequently encountered a series of mis-
diagnoses, even after hospitalization. In some cases, the
misdiagnosis was frightening and grave (e.g. cancer); in
others, it was less significant (e.g. insect bite or allergies)
and the child was sent home without treatment. Following
misdiagnosis, children suffered on-going symptoms result-
ing in a return to medical care. One caregiver described
relocating across the country to obtain a diagnosis: “She
woke up with blood in her mouth. I took her to the clinic
and they said she has an allergy… She had blood on her
nose and started vomiting blood and then we took her
three different places. And then she had the stroke…it was
on this [left] side. …They said maybe it is cancer…they
didn’t find cancer… her hair was falling out and she
was starting to bleed…I traveled by bus [from the
Eastern Cape to Cape Town.] It was only me, her, and
my little one.”
Table 3 Health system level barriers: themes and illustrative
quotations
Theme: Lack of Trained Staff
Subject 3 “At the day hospital the one nurse…it was
like she had some type of attitude with me…
when I told her is there any reason you guys
can give me why the nose is continuously
bleeding. Then she told me to just go and sit
in the waiting room…I went to doctor after
doctor and nobody could give me an
explanation. They didn’t take any bloods,
nothing. It’s my child, I know. If I know that
there is something wrong with him and for
them to ask me how do I know…How can
they tell me that when I’ve noticed the changes
as a parent? So that’s the system down
there.”
Subject 7 “[After my daughter had a stroke] they discharged
us, then we always go each and every week.
They took the test. They didn’t say anything
[in regards to diagnosis]. They just want to check
is she fine. They didn’t even give her any pills
or nothing.”
Subject 12 “[At the day hospital] they asked me to come back
because there was not a doctor there…They
didn’t actually care about the patient. I took her
to the day hospital and the nurse…asked if she
was pregnant and sent her out, she did not
examine her.”
Theme: Complex Medical System
Subject 7 “I went the first time and they [nursing staff] said
I wouldn’t be called [to be seen.] I went back a
few days later and asked to see the social worker.”
Subject 10 “She had pain in her joints and an earache. They only
looked at the earache at that point. So they said it
was an infection…two or three days later she
couldn’t get out of bed. I didn’t feel like that
[respected] because I complained about both things,
the joint pain and the earache, and it was sort of like
what do you want me to look at first sort of thing.
If you take a child to a doctor you like them to
see everything.”
Subject 16 “When we went to see the doctor there and at
the time I was pregnant with my other daughter,
it was very irritating. I took her to the doctor,
they took blood and everything and then they
told me I must come to [Children’s hospital] for
an appointment.”
Subject 18 “That is when the doctor said the child is sick and
must go to another hospital. They did all the tests.
Then they sent her home. They told me whatever
comes up bring the child back here…I went to the
other GP…to mention about the child having a
clotting problem…the GP told me ‘No, we are not
going to do anything.”
Theme: Misdiagnosis
Subject 1 “The GP said to me…it’s an insect bite and she gave
me something, not even an antibiotic…then his other
foot started swelling. At that stage he couldn’t wear
his shoes anymore…I had to take him in and out of
the bus because he couldn’t go upstairs. I went to the
clinic…she said immediately take the letter up to
[Children’s hospital] and she said he must stay at
the hospital.”
Table 3 Health system level barriers: themes and illustrative
quotations (Continued)
Subject 2 “She had a platelet count of 7 and they admitted
[her to the] oncology [unit.] One day they tell you
one thing, then the next day it’s something else…
Every day it was something different for quite some
time. It was frustrating.”
Subject 15 “They put us in an emergency ambulance, because
her [hemoglobin] was very low. They saw a specialist
in [hometown]. They thought she had Leukemia,
a rare cancer of the bone marrow, and then they
discovered it wasn’t that. They realized that they had
to find another doctor because they were worried
that she was going to die so they went to
[regional center]. So from there they were referred
to see a doctor in Cape Town. She sent us to
[the children’s hospital]… and she started
getting better.”
Fig. 1 Caregiver experience of the complex referral system in
South Africa
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Discussion
This study highlights missed opportunities for a timely
diagnosis in a pediatric SLE population in South Africa
from the patient caregiver perspective. The difficulties
this group of caregivers experienced obtaining a diagno-
sis suggest that there may be a population of children
with SLE in South Africa who never reach a rheumatolo-
gist. Timely diagnosis of pSLE is important to prevent
long-term damage and improves outcomes and life ex-
pectancy in patients with renal disease [18, 34]. SLE
patients in South Africa are at high risk for renal disease
and have higher mortality rates than patients in Europe
and North America [9, 35, 36]. Our findings suggest the
poor health outcomes may be partly explained by delays
in diagnosis as reported by caregivers.
Caregivers in this study experienced many obstacles
while navigating the health care system seeking a correct
diagnosis for their child with pSLE (Fig. 1). Various fac-
tors led to delay in first care contact including lack of
recognition of the severity of initial symptoms and the
inability to attribute symptoms to SLE. The burden of
travel and long clinic wait times required caregivers to
miss work. All caregivers without household water or
electricity were of African descent, suggesting these
caregivers were more likely to face financial burdens
which would be aggravated by missing income. Almost
all caregivers used public transportation to access the
clinic as they did not own or have access to a private ve-
hicle. Most families used taxis, the least expensive but
most dangerous form of transportation in Cape Town
[37, 38]. The “hidden costs” of access go beyond clinic
fees or medication costs, and may have caused added de-
lays in seeking care [25].
Beyond the financial challenges to pSLE care access,
social stigma around a pSLE diagnosis was commonly
reported and may have been exacerbated by lack of care-
giver knowledge of SLE. Caregivers were worried that
peers would avoid his or her child if pSLE was perceived
as contagious. Additionally, most caregivers felt inad-
equately prepared to offer an explanation to others,
allowing misperceptions to perpetuate.
Once patients made contact with the health care sys-
tem, institutional delays played a large role in delaying
diagnosis. Similar delays have been reported for pSLE
patients in other settings; for example, studies from the
United Kingdom report multiple referrals prior to diag-
nosis [39]. While such delays are not unique to South
Africa, the impact may be greater, due to provider scar-
city, structure of the referral system, long clinic waits,
and difficulty with care coordination between health
providers [40]. Language barriers and lack of education
about disease processes are also factors that have been
identified previously as delaying SLE diagnosis [41, 42].
At each step of the referral process, patient level barriers
(e.g. time and cost of transportation) are reintroduced
and multiply. Barriers at both patient and health system
may interact to magnify the length of delays (Figs. 1 and 2).
Seventy-three percent of families received an incorrect
diagnosis in their early care-seeking experiences. Care-
givers reported that providers disregarded symptoms re-
quiring urgent medical attention. Misdiagnosis delays
definitive referral and treatment, contributing to disease
progression and organ damage. Patients’ and caregivers’
trust in the medical provider is a central component in
care of chronic disease [43]. Initial delays in diagnosis
may start a cycle of distrust between health system and
patients that persist beyond diagnosis [44]. The fre-
quency of misdiagnoses also suggests that young people
with SLE may remain undiagnosed in the community.
The impact of poorly trained staff and initial misdiag-
nosis were compounded by the complexity of the medical
system in South Africa. In nearly all caregiver interviews,
first contact was with a nurse at a local clinic. A series of
referrals was required before the patients were able to see
a rheumatology specialist (Fig. 1). Patients were often dis-
playing serious organ manifestations of pSLE, such as
stroke, and the fear of dealing with these symptoms was
escalated by confusion at time of diagnosis. Even when the
diagnosing physician recognized the serious nature of the
illness, the patient often had to wait several days to see a
pediatrician and subsequently a subspecialist. One family
relocated almost 600 miles from home to access subspe-
cialty medical care.
This study has several limitations. First, it was con-
ducted at two government centers and one private insti-
tution, all located in an urban location (Cape Town),
causing potential selection bias in the study sample.
However, 80% of the South African population uses the
public sector for health care [45] and the only pSLE pro-
viders in the region are located at these centers, which
increases the likelihood of representative sampling. We
used a semi-structured interview process; therefore, we
did not have equal depth across all topics, based on
participant responses. These interviews were conducted
months to years after SLE diagnosis, which could intro-
duce recall bias. Caregivers of SLE patients may remem-
ber details of diagnosis differently than the general
population would, as they have ongoing interaction with
the disease, providers, and the health care system. The
greatest limitation is that the caregivers interviewed had
overcome barriers and reached diagnosis and linkage to
specialized rheumatology care. This cohort had access to
specific resources and exhibited remarkable resilience
that may differ from families whose children with pSLE
remained undiagnosed, or who have not successfully
linked to subspecialized care for SLE treatment. While
some of our caregivers received social grants to bolster
household income, with grant assistance none were
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below the poverty line. Access to financial resources
may have increased the likelihood of successful linkage
to subspecialty care for caregivers in this study.
The findings of this study highlight possible interven-
tions to improve diagnosis efficiency at both the caregiver
and health system level. At the caregiver level, broadcast
or online media-based public service announcements
about SLE could increase community knowledge, facilitate
timely diagnosis, and reduce public stigma of the disease
[46, 47]. Caregivers would benefit from improved educa-
tion at diagnosis, which is central to successfully managing
chronic disease [48]. A standardized education packet,
combined with web-based modules and videos, could fill
the SLE education gap for caregivers of all literacy levels
at time of diagnosis [49, 50].
At the health system level, inadequate provider know-
ledge and resulting misdiagnosis delayed care. South
Africa has a great need for additional pediatric rheumatol-
ogy providers. Continued efforts to train pediatric rheu-
matologists in South Africa are critical, but will require
years to alleviate the current severe shortage. Training
existing primary care providers to recognize the signs
and symptoms of SLE would likely increase provider
awareness and decrease time to referral. Tools such as
the American College of Rheumatology’s Lupus Initia-
tive [51] could be modified to meet the needs of South
African providers and implemented in a pilot program.
This free, web-based series of educational tools is
aimed to improve SLE diagnosis and management
amongst primary care providers in the US. Similar ini-
tiatives in the UK expose students, trainees, and general
pediatricians to pediatric rheumatology and increase
the diagnosis of rheumatic disease in childhood [52].
Short courses for direct instruction with subsidized
travel for participants could complement on-line modules
[53]. South African provider perspective on delays and
interest in rheumatology-specific training are topics which
require further research. Perhaps even more importantly,
referral networks utilizing email systems or cell phone
contact could facilitate earlier referral from primary care
providers for this life threatening disease [54].
Conclusion
Caregivers’ perspectives in navigating the pathway to an
eventual diagnosis of pSLE in South Africa highlight
profound delays in diagnosis, resulting in a lasting
Fig. 2 Interaction of the barriers to pediatric SLE diagnosis in South Africa
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impact for the patient and caregiver. While many themes
mirror findings from higher income countries, chal-
lenges are exacerbated by health care, social, and eco-
nomic disparities unique to the South African setting.
The gaps identified suggest opportunities to improve the
efficiency and effectiveness of identifying patients with
SLE in South Africa. Successful interventions that re-
duce the time to diagnosis in South Africa will provide a
model for other resource limited nations [55]. Further
investigation into the long-term impact of delays in care
on disease damage and outcomes is necessary in the
pediatric SLE population of South Africa.
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